Evidence map›Paper›PMID 33565152›Full record

ArticleAnnals of neurology2021

Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells.

Keiko Imamura, Yuichiro Yada, Yuishin Izumi, Mitsuya Morita, Akihiro Kawata, Takayo Arisato, Ayako Nagahashi, Takako Enami, Kayoko Tsukita, Hideshi Kawakami and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. A neuromuscular clinician's primer on machine learning.Journal of neuromuscular diseases · 2026
    Review
  4. Machine Learning in Stem Cell Research: From Biological Data to Clinical Translation.Computational and structural biotechnology journal · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Keiko Imamura *Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.
Yuichiro Yada *Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Yuishin IzumiDepartment of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Mitsuya MoritaDivision of Neurology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.
Akihiro KawataDepartment of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Takayo ArisatoDepartment of Neurology, National Hospital Organization Minamikyusyu Hospital, Kagoshima, Japan.
Ayako NagahashiMedical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.
Takako EnamiMedical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.
Kayoko TsukitaCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Hideshi KawakamiDepartment of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.ORCID 0000-0002-1405-0901
Masanori NakagawaDepartment of Neurology, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ryosuke TakahashiDepartment of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Haruhisa InoueMedical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.ORCID 0000-0003-4736-9537
Kyoto University · JPHiroshima University · JPJichi Medical University · JPKyoto Prefectural University of Medicine · JPNational Hospital Organization · JPTokushima University · JPTokyo Metropolitan Neurological Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In amyotrophic lateral sclerosis (ALS), early diagnosis is essential for both current and potential treatments. To find a supportive approach for the diagnosis, we constructed an artificial intelligence-based prediction model of ALS using induced pluripotent stem cells (iPSCs). Images of spinal motor neurons derived from healthy control subject and ALS patient iPSCs were analyzed by a convolutional neural network, and the algorithm achieved an area under the curve of 0.97 for classifying healthy control and ALS. This prediction model by deep learning algorithm with iPSC technology could support the diagnosis and may provide proactive treatment of ALS through future prospective research. ANN NEUROL 2021;89:1226-1233.

Indexed as

Deep LearningEarly DiagnosisInduced Pluripotent Stem CellsMotor NeuronsAgedAmyotrophic Lateral SclerosisFemaleHumansMaleMiddle Aged

Identifiers

PMID33565152
PMCPMC8247989
OpenAlexW3127420280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.